New drugs for COPD based on advances in pathophysiology
作者： Trevor T. Hansel , Rachel C. Tennant , Edward M. Erin , Andrew J. Tan , Peter J. Barnes
DOI: 10.1007/978-3-0348-7939-2_12
关键词:
摘要: There is a pressing need to develop new treatments for chronic obstructive pulmonary disease (COPD), as no currently available drug has been shown reduce the relentless progression of this disease. Furthermore, recognition global importance and rising prevalence COPD absence effective therapies now led concerted effort drugs [1, 2]. However, there have disappointingly few therapeutic advances in therapy COPD, contrast enormous made asthma management that reflect much better understanding underlying [3, 4].
springer.com
sci-hub.st 参考文章(186)
Sarah L. Dallas, Jennifer L. Rosser, Gregory R. Mundy, Lynda F. Bonewald, Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts A CELLULAR MECHANISM FOR RELEASE OF TGF-β FROM BONE MATRIX Journal of Biological Chemistry. ,vol. 277, pp. 21352- 21360 ,(2002) , 10.1074/JBC.M111663200
P K Jeffery, Structural and inflammatory changes in COPD: a comparison with asthma. Thorax. ,vol. 53, pp. 129- 136 ,(1998) , 10.1136/THX.53.2.129
Richard N Fedorak, Alfred Gangl, Charles O Elson, Paul Rutgeerts, Stefan Schreiber, Gary Wild, Stephen B Hanauer, Ann Kilian, Marielle Cohard, Alexandre LeBeaut, Brian Feagan, Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group, None, Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease Gastroenterology. ,vol. 119, pp. 1473- 1482 ,(2000) , 10.1053/GAST.2000.20229
Mark A Giembycz, 4D or not 4D - the emetogenic basis of PDE4 inhibitors uncovered? Trends in Pharmacological Sciences. ,vol. 23, pp. 548- ,(2002) , 10.1016/S0165-6147(02)02089-8
William MacNee, Oxidative stress and lung inflammation in airways disease. European Journal of Pharmacology. ,vol. 429, pp. 195- 207 ,(2001) , 10.1016/S0014-2999(01)01320-6
Thomas Müller, Peter Engels, John R. Fozard, Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition Trends in Pharmacological Sciences. ,vol. 17, pp. 294- 298 ,(1996) , 10.1016/0165-6147(96)10035-3
Edgar C. Lucey, Ronald H. Goldstein, Raphael Breuer, Brent N. Rexer, David E. Ong, Gordon L. Snider, Retinoic acid does not affect alveolar septation in adult FVB mice with elastase-induced emphysema. Respiration. ,vol. 70, pp. 200- 205 ,(2003) , 10.1159/000070068
PETER K. JEFFERY, Remodeling in Asthma and Chronic Obstructive Lung Disease American Journal of Respiratory and Critical Care Medicine. ,vol. 164, ,(2001) , 10.1164/AJRCCM.164.SUPPLEMENT_2.2106061
Jørgen Vestbo, Peter Lange, Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine. ,vol. 166, pp. 329- 332 ,(2002) , 10.1164/RCCM.2112048
Peter J. Barnes, New Concepts in Chronic Obstructive Pulmonary Disease Annual Review of Medicine. ,vol. 54, pp. 113- 129 ,(2003) , 10.1146/ANNUREV.MED.54.101601.152209